Logo image of NBBK

NB BANCORP INC (NBBK) Stock Fundamental Analysis

NASDAQ:NBBK - Nasdaq - US63945M1071 - Common Stock - Currency: USD

17.78  +0.3 (+1.72%)

After market: 17.78 0 (0%)

Fundamental Rating

4

NBBK gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 395 industry peers in the Banks industry. While NBBK is still in line with the averages on profitability rating, there are concerns on its financial health. NBBK is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NBBK had positive earnings in the past year.
In the past year NBBK had a positive cash flow from operations.
NBBK Yearly Net Income VS EBIT VS OCF VS FCFNBBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

NBBK's Return On Assets of 0.88% is in line compared to the rest of the industry. NBBK outperforms 53.92% of its industry peers.
NBBK has a Return On Equity of 6.23%. This is in the lower half of the industry: NBBK underperforms 67.59% of its industry peers.
NBBK has a Return On Invested Capital of 3.04%. This is amongst the best in the industry. NBBK outperforms 99.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NBBK is in line with the industry average of 2.64%.
The 3 year average ROIC (1.99%) for NBBK is below the current ROIC(3.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.88%
ROE 6.23%
ROIC 3.04%
ROA(3y)0.62%
ROA(5y)N/A
ROE(3y)5.18%
ROE(5y)N/A
ROIC(3y)1.99%
ROIC(5y)N/A
NBBK Yearly ROA, ROE, ROICNBBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6 8

1.3 Margins

With a Profit Margin value of 15.34%, NBBK is not doing good in the industry: 74.68% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of NBBK has declined.
NBBK's Operating Margin of 67.35% is amongst the best of the industry. NBBK outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of NBBK has grown nicely.
Industry RankSector Rank
OM 67.35%
PM (TTM) 15.34%
GM N/A
OM growth 3Y14.26%
OM growth 5YN/A
PM growth 3Y-14.62%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NBBK Yearly Profit, Operating, Gross MarginsNBBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NBBK is destroying value.
The number of shares outstanding for NBBK remains at a similar level compared to 1 year ago.
NBBK has a worse debt/assets ratio than last year.
NBBK Yearly Shares OutstandingNBBK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
NBBK Yearly Total Debt VS Total AssetsNBBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

NBBK has an Altman-Z score of -0.57. This is a bad value and indicates that NBBK is not financially healthy and even has some risk of bankruptcy.
NBBK has a Altman-Z score of -0.57. This is amongst the best in the industry. NBBK outperforms 99.49% of its industry peers.
NBBK has a debt to FCF ratio of 70.19. This is a negative value and a sign of low solvency as NBBK would need 70.19 years to pay back of all of its debts.
NBBK has a worse Debt to FCF ratio (70.19) than 86.84% of its industry peers.
A Debt/Equity ratio of 5.97 is on the high side and indicates that NBBK has dependencies on debt financing.
NBBK has a Debt to Equity ratio of 5.97. This is amonst the worse of the industry: NBBK underperforms 97.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.97
Debt/FCF 70.19
Altman-Z -0.57
ROIC/WACC0.67
WACC4.55%
NBBK Yearly LT Debt VS Equity VS FCFNBBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

NBBK has a Current Ratio of 0.05. This is a bad value and indicates that NBBK is not financially healthy enough and could expect problems in meeting its short term obligations.
NBBK has a better Current ratio (0.05) than 99.49% of its industry peers.
NBBK has a Quick Ratio of 0.05. This is a bad value and indicates that NBBK is not financially healthy enough and could expect problems in meeting its short term obligations.
NBBK has a better Quick ratio (0.05) than 99.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
NBBK Yearly Current Assets VS Current LiabilitesNBBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B 4B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 327.71% over the past year.
Measured over the past years, NBBK shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.69% on average per year.
Looking at the last year, NBBK shows a very strong growth in Revenue. The Revenue has grown by 22.30%.
Measured over the past years, NBBK shows a very strong growth in Revenue. The Revenue has been growing by 46.42% on average per year.
EPS 1Y (TTM)327.71%
EPS 3Y26.69%
EPS 5YN/A
EPS Q2Q%59.09%
Revenue 1Y (TTM)22.3%
Revenue growth 3Y46.42%
Revenue growth 5YN/A
Sales Q2Q%12.03%

3.2 Future

The Earnings Per Share is expected to grow by 30.99% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y39.18%
EPS Next 2Y30.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBBK Yearly Revenue VS EstimatesNBBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 50M 100M 150M 200M 250M
NBBK Yearly EPS VS EstimatesNBBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.82, which indicates a correct valuation of NBBK.
65.82% of the companies in the same industry are cheaper than NBBK, based on the Price/Earnings ratio.
NBBK is valuated rather cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.68, the valuation of NBBK can be described as very reasonable.
NBBK's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, NBBK is valued rather cheaply.
Industry RankSector Rank
PE 14.82
Fwd PE 9.68
NBBK Price Earnings VS Forward Price EarningsNBBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NBBK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NBBK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.46
EV/EBITDA 2.92
NBBK Per share dataNBBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NBBK's earnings are expected to grow with 30.99% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y30.99%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NBBK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NB BANCORP INC

NASDAQ:NBBK (6/27/2025, 8:00:02 PM)

After market: 17.78 0 (0%)

17.78

+0.3 (+1.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-24 2025-07-24
Inst Owners45.93%
Inst Owner Change2%
Ins Owners4.81%
Ins Owner Change85.01%
Market Cap721.33M
Analysts82.86
Price Target19.38 (9%)
Short Float %3.73%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.27%
Min EPS beat(2)3.98%
Max EPS beat(2)22.55%
EPS beat(4)2
Avg EPS beat(4)0.94%
Min EPS beat(4)-20.81%
Max EPS beat(4)22.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.06%
EPS NY rev (1m)0%
EPS NY rev (3m)5.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.82
Fwd PE 9.68
P/S 2.4
P/FCF 11.46
P/OCF 11.15
P/B 0.98
P/tB 0.98
EV/EBITDA 2.92
EPS(TTM)1.2
EY6.75%
EPS(NY)1.84
Fwd EY10.33%
FCF(TTM)1.55
FCFY8.73%
OCF(TTM)1.6
OCFY8.97%
SpS7.41
BVpS18.23
TBVpS18.23
PEG (NY)0.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.88%
ROE 6.23%
ROCE 24.25%
ROIC 3.04%
ROICexc 3.16%
ROICexgc 3.27%
OM 67.35%
PM (TTM) 15.34%
GM N/A
FCFM 20.94%
ROA(3y)0.62%
ROA(5y)N/A
ROE(3y)5.18%
ROE(5y)N/A
ROIC(3y)1.99%
ROIC(5y)N/A
ROICexc(3y)2.06%
ROICexc(5y)N/A
ROICexgc(3y)2.12%
ROICexgc(5y)N/A
ROCE(3y)15.54%
ROCE(5y)N/A
ROICexcg growth 3Y33.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.95%
ROICexc growth 5YN/A
OM growth 3Y14.26%
OM growth 5YN/A
PM growth 3Y-14.62%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 5.97
Debt/FCF 70.19
Debt/EBITDA 21.52
Cap/Depr 63.14%
Cap/Sales 0.59%
Interest Coverage 1.5
Cash Conversion 31.53%
Profit Quality 136.52%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.57
F-Score7
WACC4.55%
ROIC/WACC0.67
Cap/Depr(3y)178.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.96%
Cap/Sales(5y)N/A
Profit Quality(3y)236.98%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)327.71%
EPS 3Y26.69%
EPS 5YN/A
EPS Q2Q%59.09%
EPS Next Y39.18%
EPS Next 2Y30.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.3%
Revenue growth 3Y46.42%
Revenue growth 5YN/A
Sales Q2Q%12.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y66.49%
EBIT growth 3Y67.31%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.56%
FCF growth 3Y-0.63%
FCF growth 5YN/A
OCF growth 1Y-18.36%
OCF growth 3Y-0.5%
OCF growth 5YN/A